ImmunoScape is a Singapore-based pre-clinical biotechnology company that discovers and develops TCR cell therapies for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 11-50
Address: 1 Scotts Road 24-10
City: Singapore
State: central singapore
Zip: 228208
Country: SG
ImmunoScape is a Singapore-based pre-clinical biotechnology company that discovers and develops TCR cell therapies for the treatment of cancer.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2021 | Venture Round | 3 | $14M |
Amgen Ventures Anzu Partners EDBI UTEC - The University of Tokyo Edge Capital Partners Anzu Partners EDBI UTEC - The University of Tokyo Edge Capital Partners |
9/2022 | Venture Round | 3 | $14M |
EDBI Anzu Partners Amgen Ventures Amgen Ventures Anzu Partners EDBI |
8/2020 | Venture Round | 3 | $11M |
Anzu Partners UTEC - The University of Tokyo Edge Capital Partners NPR Holdings Anzu Partners Anzu Partners UTEC - The University of Tokyo Edge Capital Partners NPR Holdings Anzu Partners |
10/2018 | Seed Round | 1 | $3M |
UTEC - The University of Tokyo Edge Capital Partners UTEC - The University of Tokyo Edge Capital Partners UTEC - The University of Tokyo Edge Capital Partners UTEC - The University of Tokyo Edge Capital Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|